AnalystsKeay NakaeKeay Nakae's Stock Forecasts
AnalystsKeay Nakae
Analyst Ranking
Top 1%
#23 out of 3474 analysts
Average Return
+201.01%
Win Rate
41%11 out of 27
Risk vs Reward
Poor
Good
Keay Nakae's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ocugen IncOCGN | +5,554.71% | $0.22 | $12.61 | 2020-06-02 - 2021-02-09 | Strong Buy |
CareCloud IncMTBC | +104.17% | $2.40 | $4.90 | 2017-11-13 - 2018-11-14 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +62.51% | $19.39 | $31.51 | 2018-09-05 - 2019-09-06 | Strong Buy |
Mesoblast LtdMESO | +62.36% | $16.10 | $6.06 | 2020-12-03 - 2021-10-27 | Strong Sell |
Forte Biosciences IncFBRX | +33.60% | $5.06 | $3.36 | 2021-09-02 - 2021-09-20 | Strong Sell |
Keay Nakae's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
BiomX IncPHGE | 1 | Strong Buy | $16.00 | +601.75% | Maintains | 9 days ago |
Forte Biosciences IncFBRX | 2 | Hold | $3.50 | +32.08% | Upgrades | a month ago |
Mesoblast LtdMESO | 2 | Strong Sell | $6.50 | +7.26% | Maintains | 2 months ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Strong Buy | $28.00 | +30.11% | Maintains | 3 months ago |
ProQR Therapeutics NVPRQR | 1 | Strong Buy | $18.00 | +139.36% | Maintains | 3 months ago |
Arrowhead Pharmaceuticals IncARWR | 3 | Strong Buy | $94.00 | +45.76% | Maintains | 3 months ago |
Seres Therapeutics IncMCRB | 1 | Strong Buy | $16.00 | +158.48% | Maintains | 3 months ago |
Femasys IncFEMY | 1 | Strong Buy | $25.00 | +256.13% | Initiates Coverage On | 4 months ago |
Axcella Health IncAXLA | 1 | Strong Buy | $10.00 | +215.46% | Maintains | 5 months ago |
Emergent BioSolutions IncEBS | 5 | Strong Buy | $92.00 | +90.75% | Maintains | 6 months ago |
Ocugen IncOCGN | 2 | Hold | $13.00 | +35.28% | Downgrades | 9 months ago |
Sonnet BioTherapeutics Holdings IncSONN | 2 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Oncocyte CorpOCX | 2 | Hold | $2.00 | N/A | Downgrades | a year ago |
NeuBase Therapeutics IncNBSE | 2 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Arbutus Biopharma CorpABUS | 1 | Strong Buy | $5.00 | N/A | Upgrades | 2 years ago |
Caladrius Biosciences IncCLBS | 1 | Strong Buy | $7.00 | N/A | Maintains | 4 years ago |
CareCloud IncMTBC | 1 | Strong Buy | $2.75 | N/A | Maintains | 4 years ago |
Biocept IncBIOC | 1 | Strong Buy | $2.50 | N/A | Initiates Coverage On | 4 years ago |
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.